Anti-clotting agent does not improve outcomes of patients with severe pneumonia

Tuesday, February 22, 2011 - 12:01 in Health & Medicine

Use of the blood clot-inhibiting medication tifacogin does not appear to improve outcomes of patients with severe community-acquired pneumonia (sCAP), according to a study conducted by researchers...

Read the whole article on Science Blog

More from Science Blog

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net